Neurogene (NGNE) Intangibles (2019 - 2022)

Neurogene (NGNE) posted Intangibles of $18000.0 for Q2 2022, down 75.34% on a QoQ basis from $73000.0 in Q1 2022, and down 92.44% year-over-year from $238000.0 in Q2 2021.

Neurogene (NGNE) Intangibles (2019 - 2022) Analysis & Trends

Neurogene's Intangibles history runs 4 years deep, the most recent figure standing at $18000.0 for Q2 2022.

  • Quarterly Intangibles fell 92.44% year-over-year to $18000.0 in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $18000.0 (down 92.44% YoY) and the FY2021 annual result came in at $128000.0, down 63.11% from the prior year.
  • Intangibles was $18000.0 for Q2 2022 at Neurogene, down from $73000.0 in the prior quarter.
  • Across five years, Intangibles topped out at $622000.0 in Q3 2019 and bottomed at $18000.0 in Q2 2022.
  • A 4-year average of $320250.0 and a median of $320000.0 in 2020 frame the typical range for Intangibles.
  • Annual changes were most pronounced in 2020 — Intangibles slumped 35.21% — and 2022, when it plunged 92.44%.
  • Neurogene's Intangibles stood at $567000.0 in 2019, then tumbled by 38.8% to $347000.0 in 2020, then sank by 63.11% to $128000.0 in 2021, then plunged by 85.94% to $18000.0 in 2022.
  • Business Quant data shows NGNE's Intangibles at $18000.0 in Q2 2022, $73000.0 in Q1 2022, and $128000.0 in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 16.97 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 11,640.44
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 61.68 Mn
4 NuCana 279.75 Bn 279.75 Bn - 2.92 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 418.50 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 1.29 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 266.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 55.80 Mn
10 Neurogene 17.50 Mn 17.50 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2022 18,000.00
Mar 31, 2022 73,000.00
Dec 31, 2021 128,000.00
Sep 30, 2021 183,000.00
Jun 30, 2021 238,000.00
Mar 31, 2021 293,000.00
Dec 31, 2020 347,000.00
Sep 30, 2020 403,000.00
Jun 30, 2020 458,000.00
Mar 31, 2020 513,000.00
Dec 31, 2019 567,000.00
Sep 30, 2019 622,000.00